Brain perfusion abnormalities in Alzheimer's disease: comparison between patients with focal temporal lobe dysfunction and patients with diffuse cognitive impairment
A. Cappa et al., Brain perfusion abnormalities in Alzheimer's disease: comparison between patients with focal temporal lobe dysfunction and patients with diffuse cognitive impairment, J NE NE PSY, 70(1), 2001, pp. 22-27
Objectives-Patients with Alzheimer's disease (AD) showing a selective impai
rment of episodic and semantic memory have recently been classified as affe
cted by focal temporal lobe dysfunction (FTLD) and considered as a distinct
subgroup of patients affected by a particular form of AD. The aim was to c
ompare the cerebral perfusion of patients with AD with FTLD and patients wi
th AD with the more typical profile of diffuse cognitive impairment (dAD).
Methods-Ten patients with AD with FTLD, 14 patients with AD with dAD, and 1
2 normal controls were studied. All the 24 patients with AD underwent a com
plete neuropsychological assessment. SPECT examination with [Tc-99m]-HMPAO,
using a four head brain dedicated tomograph, was performed in patients and
controls. Tracer uptake was quantified in 27 regions of interest (ROIs), i
ncluding lateral and mesial temporal areas. Mean counts in the 27 ROIs of c
ontrols, patients with FTLD and those with dAD were compared using an ANOVA
for repeated measures with Bonferroni's correction. A logistic regression
analysis, followed by a receiver operating characteristic (ROC) analysis, w
as also applied to select SPECT patterns which significantly differentiated
patients with FTLD and those with dAD.
Results-Two scintigraphic patterns of abnormalities, shaping a double disso
ciation between the FTLD and dAD groups, emerged: a bilateral mesial tempor
al hypoperfusion, characteristic of FTLD and a posterior parietal (and temp
oral parietal) hypoperfusion characteristic of patients with dAD.
Conclusions-These scintigraphic findings provide further support to the hyp
othesis that FTLD is not a mere stage but a distinct anatomoclinical form o
f AD. The combination of neuropsychological tests and [Tc-99m]-HMPAO SPECT
may be very useful in identifying patients with FTLD from the wider group o
f patients with dAD. This issue is particularly worthwhile, as there is inc
reasing evidence that patients with FTLD have a slower rate of cognitive de
cline.